This website is intended for healthcare professionals

Breast cancer encompasses at least four main subtypes (Nature 2012 490:61-70). Around one in five breast cancers express a gene called HER2. HER2-positive cancers grow and spread especially aggressively.

J Nat Cancer Institute 2014 doi: 10.1093/jnci/dju169

Breast cancer encompasses at least four main subtypes (Nature 2012 490:61-70). Around one in five breast cancers express a gene called HER2. HER2-positive cancers grow and spread especially aggressively.

Trastuzumab (Herceptin), the first line treatment for HER2-positive cancers, blocks signals promoting growth sent from protein encoded by HER2. However, up to 70% of patients do not respond to or develop resistance to trastuzumab. Researchers,, have shown that a protein called avß6 helps breast cancer cells grow and spread.

Researchers analysed breast cancer samples from 2992 patients. Normal breast tissue did not express avß6. However, 40% of tumours from HER2-positive patients expressed avß6. After adjusting for other tumour features, patients with high levels of avß6 in their tumour were 60% more likely to die within five years of diagnosis than those with low levels. Those overexpressing both HER2 and avß6 were 97% more likely to die. In a subgroup of 1026 people, 30.9% of patients without avß6 had distant metastases, a statistically significant difference, compared with 39.5% of those who overexpressed the integrin.

Register now for access

Thank you for visiting Independent Nurse and reading some of our premium content. To read more, please register today. 

Register

Already have an account? Sign in here